Long-term cost and effect on quality of life of osteoporosis-related fractures in Sweden
- PMID: 18484255
- DOI: 10.1080/17453670710015094
Long-term cost and effect on quality of life of osteoporosis-related fractures in Sweden
Abstract
Background and purpose: Few economic or quality-of-life studies have investigated the long-term consequences of fragility fractures. This prospective observational data collection study assessed the cost and quality of life related to hip, vertebral, and wrist fracture 13-18 months after the fracture, based on 684 patients surviving 18 months after fracture.
Patients and methods: Data regarding resource use and quality of life related to fractures was collected using questionnaires at 7 research centers in Sweden. Information was collected using patient records, register sources, and by asking the patient. Quality of life was estimated using the EQ-5D questionnaire. Direct and indirect costs were estimated from a societal standpoint.
Results: The mean fracture-related cost 13-18 months after a hip, vertebral, or wrist fracture were estimated to be euro2,422, euro3,628, and euro316, respectively. Between 12 and 18 months after hip, vertebral, and wrist fracture, utility increased by 0.03, 0.05, and 0.02, respectively. Compared to prefracture levels, the mean loss in quality of life between 13 and 18 months after fracture was estimated to be 0.05, 0.11, and 0.005 for hip, vertebral, and wrist fracture.
Interpretation: The sample of vertebral fracture patients was fairly small and included a high proportion of fractures leading to hospitalization, but the results indicate higher long-term costs and greater loss in quality of life related to vertebral fracture than previously believed.
Similar articles
-
Costs and quality of life associated with osteoporosis-related fractures in Sweden.Osteoporos Int. 2006;17(5):637-50. doi: 10.1007/s00198-005-0015-8. Epub 2005 Nov 9. Osteoporos Int. 2006. PMID: 16283064
-
The societal burden of osteoporosis in Sweden.Bone. 2007 Jun;40(6):1602-9. doi: 10.1016/j.bone.2007.02.027. Epub 2007 Mar 7. Bone. 2007. PMID: 17433804
-
Cost analysis of osteoporotic hip fractures.J Med Assoc Thai. 2005 Oct;88 Suppl 5:S96-104. J Med Assoc Thai. 2005. PMID: 16869109
-
[Epidemiology of osteoporosis].Schweiz Med Wochenschr. 1997 Apr 19;127(16):659-67. Schweiz Med Wochenschr. 1997. PMID: 9198892 Review. German.
-
[Absolute risk for fracture and WHO guideline. Economic analysis of pharmacotherapy for osteoporosis].Clin Calcium. 2007 Jul;17(7):1029-34. Clin Calcium. 2007. PMID: 17607069 Review. Japanese.
Cited by
-
Predicting EQ-5D-US and SF-6D societal health state values from the Osteoporosis Assessment Questionnaire.Osteoporos Int. 2012 Feb;23(2):723-32. doi: 10.1007/s00198-011-1619-9. Epub 2011 Apr 12. Osteoporos Int. 2012. PMID: 21484360 Free PMC article.
-
The burden of osteoporotic hip fractures in Portugal: costs, health related quality of life and mortality.Osteoporos Int. 2015 Nov;26(11):2623-30. doi: 10.1007/s00198-015-3171-5. Epub 2015 May 19. Osteoporos Int. 2015. PMID: 25986386
-
Bisphosphonate alternative regimens for the prevention of osteoporotic fragility fractures: BLAST-OFF, a mixed-methods study.Health Technol Assess. 2024 Apr;28(21):1-169. doi: 10.3310/WYPF0472. Health Technol Assess. 2024. PMID: 38634483 Free PMC article.
-
A critical review of the long-term disability outcomes following hip fracture.BMC Geriatr. 2016 Sep 2;16(1):158. doi: 10.1186/s12877-016-0332-0. BMC Geriatr. 2016. PMID: 27590604 Free PMC article. Review.
-
Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis.Osteoporos Int. 2011 Mar;22(3):967-82. doi: 10.1007/s00198-010-1424-x. Epub 2010 Oct 9. Osteoporos Int. 2011. PMID: 20936401 Free PMC article.